Form 4: Paychex Director Kevin Price Reports Future Equity Awards
Insider Transaction Report
Paychex Inc. Director Kevin A. Price has reported the future acquisition of restricted stock units and stock options effective July 15, 2025, as part of the company's incentive plan.
Summary
- Kevin A. Price, a Director at Paychex Inc., reported the future acquisition of 164 restricted stock units (RSUs) and 670 stock options, effective July 15, 2025.
- The 164 restricted stock units were awarded at a price of $0 and are subject to vesting pursuant to the Amended and Restated 2002 Stock Incentive Plan.
- The 670 newly acquired stock options have an exercise price of $140.68, become exercisable on July 15, 2026, and expire on July 14, 2035.
- Following these transactions, Kevin A. Price will beneficially own 3,226 shares of common stock.
- Price will also beneficially own a total of 15,505 stock options, including the newly acquired 670 options and previously held options with exercise prices ranging from $112.67 to $121.63.
- A Limited Power of Attorney, executed on July 12, 2024, designates Prabha S. Bhandari and Robert L. Schrader as attorneys-in-fact to handle Kevin A. Price's SEC Section 16 reporting obligations for Paychex, Inc. securities.
Sentiment
Score: 7
Explanation: The document reports the grant of equity awards to a director, which is a positive event for the individual and generally viewed as a standard practice to align management incentives with shareholder interests.
Positives
- The grant of 164 restricted stock units and 670 stock options to a director aligns management's interests with those of shareholders.
- The awards are part of an established incentive plan, indicating a structured approach to executive compensation.
Risks
- The Limited Power of Attorney explicitly states that it does not relieve the reporting person (Kevin A. Price) from responsibility for compliance with obligations under the Securities Exchange Act of 1934, including reporting requirements under Section 16.
Future Outlook
The document details future vesting and exercisability dates for the awarded securities, specifically that the newly acquired stock options will become exercisable on July 15, 2026, and expire on July 14, 2035.
Industry Context
This filing represents a routine insider transaction, common across publicly traded companies, detailing equity compensation for a director. Such awards are standard practice for aligning management incentives with shareholder value through equity ownership.
Comparison to Industry Standards
- The grant of restricted stock units and stock options to a director is a common form of executive and director compensation across various industries, including the business services sector where Paychex operates.
- The use of a stock incentive plan (Amended and Restated 2002 Stock Incentive Plan) is a standard corporate governance practice for attracting, retaining, and motivating key personnel by providing them with a direct stake in the company's performance.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Delegation of Authority | Kevin A. Price granted a Limited Power of Attorney to Prabha S. Bhandari and Robert L. Schrader to prepare, execute, acknowledge, deliver, and file Forms 3, 4, and 5 with the SEC on his behalf, related to his Paychex, Inc. securities. | July 12, 2024 | This delegation streamlines compliance with SEC Section 16 reporting requirements for the director, ensuring timely and accurate filings of insider transactions. |
Related Party Transactions
- The acquisition of restricted stock units and stock options by Kevin A. Price, a director of Paychex Inc., from the company itself constitutes a related party transaction, as it involves compensation from the issuer to a member of its management.
Stakeholder Impact
- Shareholders: The equity awards align the director's financial interests with the long-term performance and value creation for shareholders.
- Employees: While not directly impacted, the compensation structure for directors can reflect the company's broader philosophy on incentivizing performance.
Next Steps
- Vesting of the 164 restricted stock units, subject to the terms of the Amended and Restated 2002 Stock Incentive Plan.
- The 670 newly acquired stock options will become exercisable on July 15, 2026.
- The 670 newly acquired stock options will expire on July 14, 2035.
Key Dates
| Date | Description |
|---|---|
| 07/15/2022 | Date existing stock options with an exercise price of $112.67 became exercisable. |
| 07/15/2023 | Date existing stock options with an exercise price of $115 became exercisable. |
| 07/12/2024 | Date the Limited Power of Attorney was executed by Kevin A. Price. |
| 07/15/2024 | Date existing stock options with an exercise price of $120.86 became exercisable. |
| 07/15/2025 | Date of earliest transaction for the acquisition of 164 restricted stock units and 670 stock options. |
| 07/15/2025 | Date existing stock options with an exercise price of $121.63 became exercisable. |
| 07/17/2025 | Signature date of the Form 4 filing by Prabha S. Bhandari, Attorney-in-fact. |
| 05/05/2026 | Expiration date of the Notary Public's commission for the Power of Attorney. |
| 07/15/2026 | Date the newly acquired stock options with an exercise price of $140.68 become exercisable. |
| 07/14/2031 | Expiration date of existing stock options with an exercise price of $112.67. |
| 07/14/2032 | Expiration date of existing stock options with an exercise price of $115. |
| 07/14/2033 | Expiration date of existing stock options with an exercise price of $120.86. |
| 07/14/2034 | Expiration date of existing stock options with an exercise price of $121.63. |
| 07/14/2035 | Expiration date of the newly acquired stock options with an exercise price of $140.68. |
Keywords
Paychex, PAYX, Form 4, SEC filing, insider transaction, stock options, restricted stock units, RSU, director compensation, executive compensation, Section 16, beneficial ownership, stock incentive plan, corporate governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.